首页>
外国专利>
Rationally designed meganucleases with sequence specificity and altered DNA binding affinity
Rationally designed meganucleases with sequence specificity and altered DNA binding affinity
展开▼
机译:合理设计的大范围核酸酶具有序列特异性和改变的DNA结合亲和力
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for cleaving a double-stranded DNA target recognition sequence into a eukaryotic cell comprising: introducing into said eukaryotic cell a nucleic acid encoding a meganuclease; or a meganuclease protein; wherein said meganuclease cleaves said double stranded DNA target recognition sequence; and wherein said meganuclease is a recombinant meganuclease comprising: a polypeptide having at least 85% sequence similarity with residues 2-153 of the I-CreI meganuclease of SEQ ID NO: 1; and which has specificity for a recognition sequence semisite that differs by at least one base pair from a semisite in an I-CreI meganuclease recognition sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO : 3, SEQ ID NO: 4 and SEQ ID NO: 5, where the specificity at position -1: (i) has been altered to an A by a modification selected from the group consisting of D75C, D74L, D75Y, K139Y, T46A and T46C; (ii) to a G through a modification selected from the group consisting of T46E, T46D and T75E; or (iii) to a T by a modification selected from the group consisting of D75H, D75Q, D75Y, K139H, T46H and T46Q; (iv) to any base in a strand felt by a T46G modification. with the proviso that the method is not a method for the treatment of the human body or an animal by therapy; with the proviso that the method is not a method to modify the genetic identity of the germ line of human beings and with the additional caveat that the cell is not a human embryonic stem cell or a human blastocyst cell.
展开▼
机译:一种将双链DNA靶标识别序列切割成真核细胞的方法,包括:将编码大范围核酸酶的核酸引入所述真核细胞;或大范围核酸酶蛋白;其中所述大范围核酸酶切割所述双链DNA靶标识别序列;其中所述大范围核酸酶是重组大范围核酸酶,其包含:与SEQ ID NO:1的I-CreI大范围核酸酶的残基2-153具有至少85%序列相似性的多肽;和并且其对选自SEQ ID NO:2,SEQ ID NO:3,SEQ ID NO:1的I-CreI大范围核酸酶识别序列中的识别序列半位点与半位点具有至少一个碱基对的特异性。 4和SEQ ID NO:5,其中在位置-1处的特异性:(i)已通过选自D75C,D74L,D75Y,K139Y,T46A和T46C的修饰而改变为A; (ii)通过选自T46E,T46D和T75E的修饰而变成G; (iii)通过选自D75H,D75Q,D75Y,K139H,T46H和T46Q的修饰而形成的T; (iv)T46G修饰的毡条中的任何碱基。条件是该方法不是通过疗法治疗人体或动物的方法;前提条件是该方法不是改变人类生殖系遗传特性的方法,另外需要注意的是,该细胞不是人类胚胎干细胞或人类胚泡细胞。
展开▼